Penn Medicine's hematologists evaluate a wide variety of blood disorders and work closely with other specialists to create treatment plans.
Our dedicated team of hematologists diagnose and treat all types of blood disorders.
Penn Hematology is a nationally recognized leader in the research, diagnosis and treatment of all types of blood-related disorders ranging from the most common to the most complex.
Our hematologists are part of multidisciplinary teams whose approach to blood disorders is to treat the entire individual, not just the disease. Patients benefit from a team of experts across specialties working together to determine the best course of treatment in a supportive, compassionate environment.
Penn hematologists work very closely with oncologists at Penn Medicine's Abramson Cancer Center, a comprehensive cancer center designated by the National Cancer Institute and rated as "exceptional" in its most recent peer review.
Amyloidosis program brings together expert physicians from multiple specialties to evaluate and treat patients with systemic amyloidosis.
Our hematologists evaluate and treat non-malignant blood disorders.
Meet Penn's hematology team.
Penn's comprehensive thalassemia program provides care for adults with thalassemia.
Congratulations to the 198 Penn physicians listed below who were included in Philadelphia Magazine's Top Docs™ 2017.
Penn Medicine is one of the world’s leading academic medical centers.
A clinical trial is a research study involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions.